AtriCure (ATRC) swings to profit with a 650% Q2 2026 earnings beat
As seen on the 24/7 Wall St. homepage on July 23, 2026.
AtriCure swung to profitability with earnings that crushed expectations by 650%, posting $0.18 per share versus the $0.02 consensus, as strong demand for its cardiac surgery and pain management devices powered 13% U.S. revenue growth.
Continue ReadingShow less
AtriCure posted Q2 2026 earnings of $0.18 per share, blowing past the $0.02 consensus estimate by 650%. That result marks a meaningful milestone for the medical-device maker, which had been logging per-share losses as recently as Q2 2025, when it reported negative $0.02. The company's steady march toward the black is visible across the past several quarters — losses shrank from $0.17 in Q3 2024 to a near-breakeven $0.01 in Q3 2025, followed by its first profitable quarter at $0.06 in Q4 2025 and a nominal profit of $0.0022 in Q1 2026.
Revenue for the quarter came in at $153.6 million, edging past the $151.8 million estimate by roughly 1.2%. The card attributes the outperformance to strong demand for AtriCure's cardiac surgery and pain management devices, with U.S. revenue growing 13% over the year-ago period. The combination of top-line momentum and the swing to GAAP profitability suggests the company's operating leverage is beginning to show up in the bottom line in a more pronounced way.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ).2The probability of a member receiving $1,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
Investors will want to watch whether AtriCure can sustain positive earnings per share in coming quarters, particularly as the Q1 2026 result of $0.0022 showed how slim the margin for profit still was entering this period. The Q2 2026 beat is the largest positive surprise in the eight-quarter history shown here, with every prior quarter also beating estimates — a consistent pattern that may invite analysts to revisit their forward assumptions.
Mentioned: ATRC